Disruptive Behavioural Disorders in School-Aged Children

โ† Back to Index (๐Ÿงฌ Genetics)

Definition and Core Concepts

Diagnostic Categories and Clinical Features

Disorder Core Clinical Features and Diagnostic Criteria
Oppositional Defiant Disorder (ODD) Characterized by a persistent pattern of angry/irritable mood, argumentative/defiant behavior, or vindictiveness lasting at least 6 months. Requires at least four specific symptoms exhibited during interaction with at least one individual who is not a sibling. Classified as mild (confined to 1 setting), moderate ($\ge2settings),orsevere(\ge$3 settings).
Intermittent Explosive Disorder (IED) Defined by recurrent behavioral outbursts representing a failure to control aggressive impulses, manifesting as verbal or physical aggression. Outbursts are grossly disproportionate to the provocation or precipitating psychosocial stressors. Episodes are typically impulsive, anger-based (not premeditated), onset rapidly, and last <30 minutes.
Conduct Disorder (CD) Involves a repetitive and persistent pattern of behaviors that violate the basic rights of others or major age-appropriate societal norms over a period of at least 12 months. Symptoms are grouped into four categories: aggression to people and animals, destruction of property, deceitfulness or theft, and serious rule violations (e.g., truancy, running away). Severe early-onset behaviors carry a poor prognosis and increase the risk for antisocial personality disorder in adulthood.

Etiology and Risk Factors

Comorbidities

Management Principles

Psychosocial Interventions

Pharmacotherapy

Medication Class Clinical Application
Stimulants Highly effective in reducing oppositional behavior, anger outbursts, and aggression in youths who have comorbid ADHD.
Alpha-2 Adrenergic Agonists Agents like extended-release guanfacine are efficacious for managing oppositionality and impulsivity, specifically when comorbid with ADHD.
Atypical Antipsychotics Risperidone has strong evidence for reducing severe aggression and conduct problems; however, use is strictly reserved for severe presentations where safety is compromised due to metabolic side effects.